Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
This quick comparison outlines safety essentials between stablecoins and other crypto assets, with practical tips for cautious investors.
21,083 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Planet Labs reports a record Q4 revenue and a backlog eclipsing annual sales, spurring a sharp after hours rally as i...
As major retailers push Beyond Meat into the frozen aisle, investors debate the stock's trajectory. This guide breaks...
On a day when the markets attempted a comeback, FuboTV stunned traders with a sharp drop. This article breaks down wh...
Delek US shares jumped as crude and refining margins strengthened. This article breaks down the drivers, the risks, a...
A midweek market jolt hit the memory space as a rival unveiled AI driven compression and Sandisk announced a major in...
Two popular emerging market ETFs race for your portfolio. This guide breaks down cost, coverage, and performance to h...
FuboTV has faced a brutal stretch, yet new synergies from Disney and Hulu may set up a rebound in EBITDA and subscrib...
Investors are weighing how legal rulings against Meta could reshape risk and earnings. This guide breaks down what ha...
A surprising move in the stock market drew attention to Super Micro Computer. This article breaks down the forces beh...
Investing in obesity drugs doesn't have to be a gamble. This guide explains why a proven company with real cash flow ...
Two-thirds of the S&P 500 have reported, and the results are surprisingly strong. This could mean smoother gains for ...